A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Institut Bergonié
GI Innovation, Inc.
Actuate Therapeutics Inc.
ImmunityBio, Inc.
ImmunityBio, Inc.
Alaunos Therapeutics
European Organisation for Research and Treatment of Cancer - EORTC